Icon

INVEGA SUSTENNA (nda022264)- (39MG/0.25ML (39MG/0.25ML),78MG/0.5ML (78MG/0.5ML),117MG/0.75ML (117MG/0.75ML),156MG/ML (156MG/ML),234MG/1.5ML (156MG/ML))

PALIPERIDONE PALMITATE JANSSEN PHARMS
39MG/0.25ML (39MG/0.25ML),78MG/0.5ML (78MG/0.5ML),117MG/0.75ML (117MG/0.75ML),156MG/ML (156MG/ML),234MG/1.5ML (156MG/ML)
Yes No
2031-Jan-26 2011-Dec-19
None None
None No
INVEGA® is an atypical antipsychotic agent indicated for Treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants.
1 3 0
Total Other Developers 10
Drugs with Suitability No
39MG/0.25ML (39MG/0.25ML) ** ** - - -
78MG/0.5ML (78MG/0.5ML) ** ** Up - -
117MG/0.75ML (117MG/0.75ML) ** ** Up - -
156MG/ML (156MG/ML) ** ** Up - -
234MG/1.5ML (156MG/ML) ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.